|
US10023A
(en)
*
|
|
1853-09-20 |
|
Machine fob sawing sticks eob broom-handles |
|
US181440A
(en)
*
|
|
1876-08-22 |
|
Improvement in steam-boiler furnaces |
|
US19206A
(en)
*
|
|
1858-01-26 |
|
Hydrant |
|
US139398A
(en)
*
|
|
1873-05-27 |
|
Improvement in lamp-extinguishers |
|
US19037A
(en)
*
|
|
1858-01-05 |
|
Washing-machine |
|
US18192A
(en)
*
|
|
1857-09-15 |
|
And samuel m |
|
US171271A
(en)
*
|
|
1875-12-21 |
|
Improvement in bob-sleds |
|
US77321A
(en)
*
|
|
1868-04-28 |
|
Amos bank |
|
US19035A
(en)
*
|
|
1858-01-05 |
|
mallary |
|
US37889A
(en)
*
|
|
1863-03-10 |
|
Mode of |
|
US72500A
(en)
*
|
|
1867-12-24 |
|
Improvement in bleaceisg and scouring hemp, flax, aid other fibres |
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
DE3689123T2
(de)
|
1985-11-01 |
1994-03-03 |
Xoma Corp |
Modulare einheit von antikörpergenen, daraus hergestellte antikörper und verwendung.
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5132405A
(en)
|
1987-05-21 |
1992-07-21 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
US5010175A
(en)
|
1988-05-02 |
1991-04-23 |
The Regents Of The University Of California |
General method for producing and selecting peptides with specific properties
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
IE66205B1
(en)
|
1990-06-14 |
1995-12-13 |
Paul A Bartlett |
Polypeptide analogs
|
|
US5231114A
(en)
|
1990-06-22 |
1993-07-27 |
Wakunaga Seiyaku Kabushiki Kaisha |
Polysulfides compounds and lipid peroxidation inhibitor containing the polysulfide compounds as active ingredient
|
|
US5650489A
(en)
|
1990-07-02 |
1997-07-22 |
The Arizona Board Of Regents |
Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
|
|
US5527679A
(en)
|
1991-05-01 |
1996-06-18 |
Dana Farber Cancer Institute |
β5 protein and DNA encoding the same
|
|
DE4142366A1
(de)
*
|
1991-07-15 |
1993-06-24 |
Thomae Gmbh Dr K |
Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
DE4123341A1
(de)
*
|
1991-07-15 |
1993-01-21 |
Thomae Gmbh Dr K |
Phenylalkylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
|
|
US5777085A
(en)
|
1991-12-20 |
1998-07-07 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with GPIIB/IIIA
|
|
US6291196B1
(en)
*
|
1992-01-31 |
2001-09-18 |
Research Corporation Technologies, Inc. |
Melanoma and prostate cancer specific antibodies for immunodetection and immunotherapy
|
|
WO1993018141A1
(en)
|
1992-03-02 |
1993-09-16 |
Biogen, Inc. |
Thrombin receptor antagonists
|
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
US6210671B1
(en)
|
1992-12-01 |
2001-04-03 |
Protein Design Labs, Inc. |
Humanized antibodies reactive with L-selectin
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5593853A
(en)
|
1994-02-09 |
1997-01-14 |
Martek Corporation |
Generation and screening of synthetic drug libraries
|
|
US5539083A
(en)
|
1994-02-23 |
1996-07-23 |
Isis Pharmaceuticals, Inc. |
Peptide nucleic acid combinatorial libraries and improved methods of synthesis
|
|
US5525735A
(en)
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
|
US5549974A
(en)
|
1994-06-23 |
1996-08-27 |
Affymax Technologies Nv |
Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
|
|
US5780426A
(en)
*
|
1995-06-07 |
1998-07-14 |
Ixsys, Incorporated |
Fivemer cyclic peptide inhibitors of diseases involving αv β3
|
|
US5569588A
(en)
|
1995-08-09 |
1996-10-29 |
The Regents Of The University Of California |
Methods for drug screening
|
|
ATE308981T1
(de)
*
|
1995-08-14 |
2005-11-15 |
Scripps Research Inst |
Verfahren und mittel zur hemmung der durch alpha v beta 5 vermittelten angiogenese
|
|
US7053041B1
(en)
*
|
1996-05-31 |
2006-05-30 |
The Scripps Research Institute |
Methods and compositions useful for inhibition of αvβ5mediated angiogenesis
|
|
CZ350098A3
(cs)
|
1996-05-01 |
1999-11-17 |
Eli Lilly And Company |
Způsob léčení neoplasie
|
|
BR9711154A
(pt)
|
1996-08-12 |
1999-08-17 |
Yoshitomi Pharmaceutical |
Agente farmac-utico contendo inibidor cinase rho
|
|
UA60311C2
(uk)
*
|
1996-10-02 |
2003-10-15 |
Смітклайн Бічам Корпорейшн |
Антагоністи рецептора вітронектину, спосіб одержання цих сполук та фармацевтична композиція
|
|
CO4920232A1
(es)
*
|
1997-01-08 |
2000-05-29 |
Smithkline Beecham Corp |
Acidos aceticos dibenzo [a,d] cicloheptano con actividad antagonista del receptor de vitronectin
|
|
AR013269A1
(es)
|
1997-08-04 |
2000-12-13 |
Scras |
Producto que contiene por lo menos un rna de doble filamento combinado con por lo menos un agente anti-viral, para la utilizacion terapeutica en eltratamiento de una enfermedad viral, en especial de la hepatitis viral
|
|
ATE511850T1
(de)
*
|
1997-08-08 |
2011-06-15 |
Univ California |
Behandlung von blasenfibrose mit antikörpern gegen alpha-v-beta-6-integrin
|
|
US6506559B1
(en)
|
1997-12-23 |
2003-01-14 |
Carnegie Institute Of Washington |
Genetic inhibition by double-stranded RNA
|
|
AUPP249298A0
(en)
|
1998-03-20 |
1998-04-23 |
Ag-Gene Australia Limited |
Synthetic genes and genetic constructs comprising same I
|
|
GB9827152D0
(en)
|
1998-07-03 |
1999-02-03 |
Devgen Nv |
Characterisation of gene function using double stranded rna inhibition
|
|
DE19842415A1
(de)
|
1998-09-16 |
2000-03-23 |
Merck Patent Gmbh |
Pharmazeutische Zubereitung
|
|
HK1044159A1
(zh)
|
1998-12-01 |
2002-10-11 |
蛋白质设计实验室股份有限公司 |
抗γ-干扰素的人化抗体
|
|
WO2000038737A2
(en)
|
1998-12-30 |
2000-07-06 |
Edema Clearance, Inc. |
GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase
|
|
CA2361201A1
(en)
|
1999-01-28 |
2000-08-03 |
Medical College Of Georgia Research Institute, Inc. |
Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
|
|
DE19956568A1
(de)
|
1999-01-30 |
2000-08-17 |
Roland Kreutzer |
Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
|
|
US6399581B1
(en)
|
1999-05-11 |
2002-06-04 |
Harbor Branch Oceanographic Institution, Inc. |
Compound possessing potent thrombin receptor antagonist activity
|
|
CZ20011872A3
(cs)
|
1999-09-29 |
2002-03-13 |
Ortho-Mcneil Pharmaceutical, Inc. |
Isonipekotamidy pro léčbu onemocnění zprostředkovaných integriny
|
|
HK1047109A1
(zh)
|
1999-10-15 |
2003-02-07 |
University Of Massachusetts |
作为指定基因干预工具的rna干预轨迹基因
|
|
US6544982B1
(en)
|
1999-10-29 |
2003-04-08 |
Merck & Co., Inc. |
Thrombin receptor antagonists
|
|
GB9927444D0
(en)
|
1999-11-19 |
2000-01-19 |
Cancer Res Campaign Tech |
Inhibiting gene expression
|
|
CA2397194C
(en)
|
2000-01-20 |
2011-05-17 |
Mark E. Duggan |
Alpha v integrin receptor antagonists
|
|
CA2397665A1
(en)
|
2000-01-24 |
2001-07-26 |
Merck & Co., Inc. |
Alpha v integrin receptor antagonists
|
|
US6403612B2
(en)
|
2000-01-31 |
2002-06-11 |
Merck & Co., Inc. |
Thrombin receptor antagonists
|
|
US6515023B2
(en)
|
2000-01-31 |
2003-02-04 |
Merck & Co., Inc. |
Thrombin receptor antagonists
|
|
MXPA02007249A
(es)
|
2000-02-03 |
2002-12-09 |
Eisai Co Ltd |
Inhibidor de la expresion de integrina.
|
|
US6518244B2
(en)
|
2000-03-09 |
2003-02-11 |
Intimax Corporation |
Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof
|
|
EP1134951A3
(en)
|
2000-03-13 |
2003-05-28 |
Hyundai Electronics Industries Co., Ltd. |
Common subscriber managing apparatus and method therefor
|
|
US20020004042A1
(en)
|
2000-04-18 |
2002-01-10 |
Factor Phillip H. |
Gene therapy for pulmonary edema using adenovirus vectors encoding a beta2adrenergic receptor gene
|
|
AU2001269821A1
(en)
|
2000-06-15 |
2001-12-24 |
Barbara Chen |
Cycloalkyl alkanoic acids as integrin receptor antagonists
|
|
US7288390B2
(en)
*
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
|
DE10041423A1
(de)
|
2000-08-23 |
2002-03-07 |
Merck Patent Gmbh |
Biphenylderivate
|
|
US20020072500A1
(en)
|
2000-09-27 |
2002-06-13 |
Thomas Rogers |
Hydroxy acid integrin antagonists
|
|
DE60118025T2
(de)
|
2000-10-24 |
2006-11-23 |
Merck & Co., Inc. |
Dibenzoxazepin-alpha-v-integrin-rezeptorantagonist
|
|
CA2433680A1
(en)
|
2000-12-28 |
2002-08-01 |
Gregory M Arndt |
Double-stranded rna-mediated gene suppression
|
|
WO2002081627A2
(en)
|
2001-04-04 |
2002-10-17 |
Allergan, Inc. |
Methods of screening and using inhibitors of angiogenesis
|
|
EP1389205B1
(en)
|
2001-04-09 |
2005-12-21 |
Ortho-McNeil Pharmaceutical Research Inc. |
Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
|
|
US20040019206A1
(en)
|
2001-09-27 |
2004-01-29 |
Peter Ruminiski |
Lactone integrin antagonists
|
|
AU2003259891A1
(en)
*
|
2002-08-16 |
2004-03-19 |
Janssen Pharmaceutica N.V. |
Piperidinyl compounds that selectively bind integrins
|
|
WO2004105757A2
(en)
|
2003-05-29 |
2004-12-09 |
Schering Aktiengesellschaft |
Use of rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy
|
|
TWI552751B
(zh)
|
2011-06-20 |
2016-10-11 |
Ｈ 朗德貝克公司 |
投予４－（（１ｒ，３ｓ）－６－氯－３－苯基－二氫茚－１－基）－１，２，２－三甲基－哌及其鹽用於治療精神分裂症的方法
|